MedPath

Comparison Between Low Dose and High Dose Intra-articular Tranexamic Acid in Total Knee Arthroplasty

Phase 4
Completed
Conditions
Blood Loss, Surgical
Interventions
Registration Number
NCT03044041
Lead Sponsor
Thammasat University
Brief Summary

The purpose of this study is to compare blood loss between using low dose (500 mg) and high dose (3 g) topical intra-articular tranexamic acid after total knee arthroplasty in double-blind RCT

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Osteoarthritic knee who underwent primary total knee arthroplasty
Exclusion Criteria
  • Abnormal coagulation or bleeding disorder
  • Allergy to tranexamic acid
  • History of thromboembolism or ischemic heart disease or cerebrovascular accident
  • chronic kidney disease stage 3-4

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low doseTranexamic Acidsingle dose of intra-articular Tranexamic acid 500 miligrams
High doseTranexamic AcidSingle dose of intra-articular Tranexamic acid 3 grams
Primary Outcome Measures
NameTimeMethod
Total blood loss72 hours after TKA

Blood loos that calculated from Haemoglobin drop at 72 hours after surgery

Secondary Outcome Measures
NameTimeMethod
Functional scoreAt 6 weeks after surgery

Modified WOMAC

Rate of participants with infection0-3 months after surgery

Superficial or deep infection after TKA

Blood transfusion0-72 hours after surgery

incidence of blood transfusion after surgery

Rate of participants with thromboembolismAt 72 hours and 2 weeks after surgery

Clinical thromboembolism after surgery

Knee ROMAt 2, 6 weeks after surgery

Range of motion of the knee

Trial Locations

Locations (1)

Thammasat University

🇹🇭

Klong Luang, Pathum Thani, Thailand

© Copyright 2025. All Rights Reserved by MedPath